Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Benefits and Risks of Fosaprepitant in Patients Receiving Emetogenic Regimens.
Pritchett W, Kinsley K. Pritchett W, et al. Clin J Oncol Nurs. 2016 Oct 1;20(5):555-6. doi: 10.1188/16.CJON.555-556. Clin J Oncol Nurs. 2016. PMID: 27668376 Free PMC article.
Fosaprepitant dimeglumine (Emend IV) is an IV antiemetic that may be beneficial to patients receiving highly emetogenic regimens. ...
Fosaprepitant dimeglumine (Emend IV) is an IV antiemetic that may be beneficial to patients receiving highly emetogenic regime …
Evaluating the role of substance P in the growth of brain tumors.
Harford-Wright E, Lewis KM, Vink R, Ghabriel MN. Harford-Wright E, et al. Neuroscience. 2014 Mar 7;261:85-94. doi: 10.1016/j.neuroscience.2013.12.027. Epub 2013 Dec 27. Neuroscience. 2014. PMID: 24374326
Subsequently, A-375 human melanoma cell line was examined in vitro and found to express both SP and the NK1 receptor. Treatment with the NK1 receptor antagonist Emend IV resulted in decreased cell viability and an increase in cell death in this cell line in vitro. A …
Subsequently, A-375 human melanoma cell line was examined in vitro and found to express both SP and the NK1 receptor. Treatment with the NK1 …